Determining the Current Situation of Geriatric Oncology in Turkey: A Survey of Medical Oncologists

Abstract

cer patients is 70 years and above.1 Recently, the rising life expectancy in the general population coupled with a disproportionate cancer burden among individuals aged 70 years and older have enthralled considerable interest in ensuring improved cancer treatment for the geriatric population.2 Significant limitation persists regarding optimal cancer treatment for older patients. Unique challenges are witnessed in the management of geriatric cancer patients. A thorough examination of the older person’s health status can aid in the assessment of risks and benefits of cancer treatment, affect the choice and intensity of treatment, and guide supportive care strategies.3 The central domains of geriatric assessment (GA) include physical and cognitive function assessment, comorbid medical problems, diet, medications, and psychological conditions.4 Despite the recommendations of the International Society of Geriatric Oncology (SIOG) and the National Comprehensive Cancer Network (NCCN), time restrictions mostly impede the systematic implementation of the application of geriatric assessment in oncology practice.5,6 To collect data without the time commitment and stress on patients and caregivers, cancer-specific geriatric evaluation tools have been designed.7 Nevertheless, the implementation of geriatric evaluation in daily medical oncology practice remains elusive.